Listed

TherapeuticsMD, Inc.

TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31

Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

TherapeuticsMD, Inc., Reports and events
FiledFormWhat it isAccession number
2021-09-1717:00 ET8-K3.01 Delisting notice0001564590-21-048250
2021-09-0706:50 ET8-K8.01 Other events0001564590-21-047142
2021-08-0916:35 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-042695
2021-08-0416:56 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-040907
2021-08-0407:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-040490
2021-05-2817:01 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-177164
2021-05-0616:56 ET10-QQuarterly reportPeriod 2021-03-310001193125-21-153419
2021-05-0607:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-152445
2021-04-1417:14 ETDEF 14AProxy statementPeriod 2021-05-270001193125-21-116458
2021-04-1206:55 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001387131-21-004324
2021-03-0419:48 ET10-KAnnual reportPeriod 2020-12-310001387131-21-003140
2021-03-0207:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-21-003075
2021-02-1608:35 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001387131-21-002393
2021-01-1308:50 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-21-000535
2020-11-2716:35 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001387131-20-010302
2020-11-1321:18 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-291974
2020-11-0909:22 ET10-QQuarterly reportPeriod 2020-09-300001387131-20-009695
2020-11-0906:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-009685
2020-09-1406:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-008293
2020-08-0718:38 ET10-QQuarterly reportPeriod 2020-06-300001387131-20-007144
2020-08-0606:56 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-007080
2020-06-2306:51 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-005881
2020-06-1816:21 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001387131-20-005767
2020-06-0106:52 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-005353
2020-05-1517:03 ET8-K1.02 Termination of a material agreement; 8.01 Other events0001387131-20-004921
2020-05-1307:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-004678
2020-05-0617:23 ET10-QQuarterly reportPeriod 2020-03-310001387131-20-004479
2020-05-0606:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-004451
2020-05-0417:01 ETDEF 14AProxy statementPeriod 2020-06-180001387131-20-004409
2020-05-0117:10 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001387131-20-004356
2020-04-2921:48 ET10-K/AAnnual report, amendedPeriod 2019-12-310001387131-20-004224
2020-04-2217:02 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001387131-20-004062
2020-03-2616:06 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001387131-20-003271
2020-03-2407:53 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-003130
2020-03-0307:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-002411
2020-02-2416:18 ET10-KAnnual reportPeriod 2019-12-310001387131-20-002086
2020-02-2006:57 ET8-K2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-001953
2020-01-1406:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-20-000236
2019-12-3007:02 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-009918
2019-12-1817:27 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-009657
2019-11-1906:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-008853
2019-11-0816:17 ET10-QQuarterly reportPeriod 2019-09-300001387131-19-008469
2019-11-0616:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-008376
2019-10-2908:52 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-19-277097
2019-10-2317:25 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-272703
2019-10-1507:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-007619
2019-10-0107:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-007303
2019-09-2506:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-007118
2019-09-1606:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-006944
2019-08-0915:00 ET10-QQuarterly reportPeriod 2019-06-300001387131-19-005935

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.